Are Alcoholism Treatments Effective? The Project MATCH Data: Response

Miller, William R.
January 2005
BMC Public Health;2005, Vol. 5 Issue 1, p76
Academic Journal
The article discusses the response of Project MATCH (Matching Alcoholism Treatments to Client Heterogeneity) on statements stating the ineffectiveness of alcoholism treatments. The authors are not recommending to stop alcoholism treatment. Still, they hold their claims despite the logical flaws and scientific misstatements which are emphasized in the review process.


Related Articles

  • Are alcoholism treatments effective? The Project MATCH data. Cutler, Robert B.; Fishbain, David A. // BMC Public Health;2005, Vol. 5 Issue 1, p75 

    Background: Project MATCH was the largest and most expensive alcoholism treatment trial ever conducted. The results were disappointing. There were essentially no patient-treatment matches, and three very different treatments produced nearly identical outcomes. These results were interpreted post...

  • CLINICAL NEPHROLOGY - EPIDEMIOLOGY - CLINICAL TRIALS Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Pannu, Neesh; Manns, Braden; Lee, Helen; Tonelli, Marcello // Kidney International;Apr2004, Vol. 65 Issue 4, p1366 

    Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Background. The efficacy of N-acetylcysteine (NAC) for preventing contrast nephropathy is uncertain. We performed a systematic review and meta-analysis to assess the efficacy of NAC for preventing contrast nephropathy...

  • Meta-Analysis of Multi-Arm Trials Using Empirical Logistic Transform. Chootrakool, Hathaikan; Jian Qing Shi // Open Medical Informatics Journal;2008, Vol. 2, p112 

    Meta-analysis of multi-arm trials has been used increasingly in recent years. The aim of meta-analysis for multi-arm trials is to combine evidence from all possible similar studies. In this paper we propose normal approximation models by using empirical logistic transform to compare different...

  • JAMA: Examination of registered clinical trials suggests weakness in size and methodology of many studies.  // Biomedical Market Newsletter;5/7/2012, Vol. 21, p1 

    The article offers information on the clinical studies registered during 2007-2010 in clinicaltrials.gov which showed heterogeneity in methodological approaches.

  • Estimating the Power of Indirect Comparisons: A Simulation Study. Mills, Edward J.; Ghement, Isabella; O'Regan, Christopher; Thorlund, Kristian // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Background: Indirect comparisons are becoming increasingly popular for evaluating medical treatments that have not been compared head-to-head in randomized clinical trials (RCTs). While indirect methods have grown in popularity and acceptance, little is known about the fragility of confidence...

  • Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. Cicero, A. F. G.; Gerocarni, B.; Laghi, L.; Borghi, C. // Journal of Human Hypertension;Jul2011, Vol. 25 Issue 7, p425 

    The oral assumption of lactotripeptides Valine-Proline-Proline (VPP) and Isoleucine-Proline-Proline (IPP) as nutraceuticals or functional foods is supposed to improve blood pressure (BP) control by angiotensin-converting enzyme-inhibition. However, data derived from clinical trials have reached...

  • Clinical Experience Using Vitamin D and Analogs in the Treatment of Myelodysplasia and AcuteMyeloid Leukemia: A Review of the Literature. Harrison, Jonathan S.; Bershadskiy, Alexander // Leukemia Research & Treatment;2012, p1 

    Despite progress in understanding the biology of acute myeloid leukemia (AML), and despite advances in treatment, the majority of patients with AML die from the disease. The observation that Vitamin D can induce AML blast cells in vitro to differentiate along the monocytic lineage was made 30...

  • Hope and the limits of research. Daugherty, Christopher K.; Geller, Gail // Hastings Center Report;Sep/Oct96, Vol. 26 Issue 5, p20 

    Opinion. Presents two views on whether a breast cancer patient should be included in the clinical trial of a new chemotherapy agent considering the problems that may arise from the situation. Right of patients to participate in an experimental therapy when there is no more other hope of...

  • Early Treatment to Prevent Glaucoma.  // HealthFacts;May2003, Vol. 28 Issue 5, p6 

    Focuses on two clinical trials regarding the early treatment of glaucoma. Results of clinical trials for glaucoma drugs; Information on the reduction of intraocular pressure to prevent glaucoma from progressing.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics